By Andrea Ochoa and Victoria Watts
The direct-to-patient clinical trial model has gained popularity in recent years, and social distancing concerns have only accelerated this trend. In this model, on-site clinical assessments are limited, and study materials are delivered to patients at home to minimize site visits and provide added convenience for participants. While this arrangement offers many advantages, there are some things to consider before jumping in.
Andrea Ochoa, Premier Research’s Vice President of Global Study Start-Up, and Victoria Watts, our Global Data Protection Officer, join Dr. June Chen this episode to discuss these topics, including:
- What to consider when using technology solutions to ensure data integrity
- How to protect patient privacy
- What recent events suggest about the “new normal” for clinical research